Without a doubt, the brightest star in the summer night sky is Arcturus. It’s the second-brightest star in our night skies throughout the year. Only Sirius, the brightest star in the constellation ...
Arcturus Therapeutics believes it’s “highly unlikely” it will lose the promised government funding for its bird flu mRNA vaccine trial, despite reports swirling that Moderna’s own financial support ...
Hosted on MSN
Arcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeutics
Earnings Call Insights: Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2025 Joe Payne, President and CEO, highlighted heightened interest in the company's mRNA therapeutics pipeline, pointing to ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20260303197744/en/ The articles, information, and content displayed on this webpage ...
San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. In a brief ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...
Sept 23 (Reuters) - Biotech company Arcturus Therapeutics (ARCT.O), opens new tab sued AbbVie (ABBV.N), opens new tab in California federal court on Tuesday for allegedly stealing trade secrets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results